Gautam G Rao

Summary

Affiliation: Vanderbilt University
Country: USA

Publications

  1. ncbi Hormonal therapy in epithelial ovarian cancer
    Gautam G Rao
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, B 1100 MCN, Nashville, TN 37232 2516, USA
    Expert Rev Anticancer Ther 6:43-7. 2006
  2. ncbi Fertility-sparing surgery for ovarian low malignant potential tumors
    Gautam G Rao
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, J7.124, Dallas, TX 75390-9032, USA
    Gynecol Oncol 98:263-6. 2005
  3. ncbi Gestational trophoblastic disease among Hispanic women: a 21-year hospital-based study
    Richard D Drake
    Southwestern Trophoblastic Disease Center, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
    Gynecol Oncol 103:81-6. 2006
  4. ncbi Duration of human chorionic gonadotropin surveillance for partial hydatidiform moles
    Isaac Lavie
    Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas 75390-9032, USA
    Am J Obstet Gynecol 192:1362-4. 2005
  5. ncbi Clinical applications of hormonal therapy in ovarian cancer
    Gautam G Rao
    University of Texas Southwestern Medical Center, Department of Obstetrics and Gynecology, 5323 Harry Hines Blvd, Dallas, TX 75390, USA
    Curr Treat Options Oncol 6:97-102. 2005
  6. ncbi Transitional cell ovarian carcinoma in a BRCA1 mutation carrier
    Gautam G Rao
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Obstet Gynecol 99:944-6. 2002
  7. ncbi Surgical staging of ovarian low malignant potential tumors
    Gautam G Rao
    Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Obstet Gynecol 104:261-6. 2004

Collaborators

Detail Information

Publications7

  1. ncbi Hormonal therapy in epithelial ovarian cancer
    Gautam G Rao
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, B 1100 MCN, Nashville, TN 37232 2516, USA
    Expert Rev Anticancer Ther 6:43-7. 2006
    ....
  2. ncbi Fertility-sparing surgery for ovarian low malignant potential tumors
    Gautam G Rao
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, J7.124, Dallas, TX 75390-9032, USA
    Gynecol Oncol 98:263-6. 2005
    ..CONCLUSION: Fertility-sparing surgery for ovarian LMP tumors is an option for motivated patients. Preservation of the contralateral adnexa increases the risk of recurrence, but surgical resection is usually curative...
  3. ncbi Gestational trophoblastic disease among Hispanic women: a 21-year hospital-based study
    Richard D Drake
    Southwestern Trophoblastic Disease Center, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
    Gynecol Oncol 103:81-6. 2006
    ..1, 2.2). CONCLUSION: Hispanic women had the highest incidence of GTD in this hospital-based study, were diagnosed at an earlier gestational age in the last decade and more frequently were diagnosed with partial moles...
  4. ncbi Duration of human chorionic gonadotropin surveillance for partial hydatidiform moles
    Isaac Lavie
    Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas 75390-9032, USA
    Am J Obstet Gynecol 192:1362-4. 2005
    ..CONCLUSION: Our results support the suggestion that a single undetectable human chorionic gonadotropin level after evacuation is sufficient follow-up to ensure remission in patients with partial hydatidiform moles...
  5. ncbi Clinical applications of hormonal therapy in ovarian cancer
    Gautam G Rao
    University of Texas Southwestern Medical Center, Department of Obstetrics and Gynecology, 5323 Harry Hines Blvd, Dallas, TX 75390, USA
    Curr Treat Options Oncol 6:97-102. 2005
    ..Because of the endocrine associations with ovarian cancer, the minimal side effects, and demonstrated activity of hormonal therapies in other endocrine-associated malignancies, further study is needed...
  6. ncbi Transitional cell ovarian carcinoma in a BRCA1 mutation carrier
    Gautam G Rao
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Obstet Gynecol 99:944-6. 2002
    ..Comprehensive gene sequence analysis detected the germline BRCA1 5382insC mutation. CONCLUSION: Transitional cell ovarian carcinoma is a rare histologic variant of epithelial ovarian cancer that may occur in BRCA1 mutation carriers...
  7. ncbi Surgical staging of ovarian low malignant potential tumors
    Gautam G Rao
    Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Obstet Gynecol 104:261-6. 2004
    ..4%) death occurred after a median follow-up of 28 (range, 1-208) months. CONCLUSION: Routine pelvic and para-aortic lymph node dissection is not necessary in the majority of women with ovarian low malignant potential tumors...